Identification of a metabolic signature to predict overall survival for colorectal cancer. (2nd September 2021)

• Record Type: Journal Article
• Authors: Yuan, Yitao; Liu, Mengling; Hou, Pengcong; Liang, Li; Sun, Xun; Gan, Lu; Liu, Tianshu
• Is Part Of: Scandinavian journal of gastroenterology. Volume 56:Number 9(2021)
• Page Start: 1078
• Page End: 1087
• Publication Date: 2021-09-02
• Subjects: Metabolic gene -- colorectal cancer -- nomogram -- prognosis -- biomarker; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; 616.33
• DOI: 10.1080/00365521.2021.1948605
• Languages: English
• ISSNs: 0036-5521

Abstract

Abstract: Purpose: Metabolic genes are associated with the occurrence and development of tumors. Metabolic-related risk models have showed partly prognostic predictive ability in cancers. However, the correlation between metabolic-related genes (MRGs) and the outcome of colorectal cancer is still poorly understood. Patients and methods: TCGA database is used as the training cohort; while GSE39582 is the verification cohort. The least absolute shrinkage and selection operator Cox regression analysis were utilized to identify the MRGs and establish a genetic risk scoring model. A nomogram by integrating MRGs risk scores with TNM stage was constructed. The potential biological mechanisms were explored using gene set enrichment analysis. Associations of the signature with immune cell infiltrations and the tumor mutation burden (TMB) were also uncovered by Spearman rank test. Results: A six-gene metabolic signature was identified. Based on the risk scoring model with the signature, patients were divided into two groups (high-risk versus low-risk). The overall survival (OS) duration of patients with high-risk were quite shorter than those of low-risk patients (TCGA: p < .001, GSE39582: p < .001). Metabolic-related pathways were major enriched in low-risk group, while the high-risk group exhibited multiple immune-related pathways. Moreover, our signature was more linear dependent with antigen-presenting cell than effector immune cells, and a positive correction were seen between our signature and TMB. Conclusion: Our research has discovered a six-gene metabolic signature to predict the OS of colorectal cancer. These genes may play significant roles in colorectal cancer regulating tumor microenvironment and serving as potential biomarkers for anti-cancer therapy.